Reference
Sakaguchi T, Itoh H, Ding W-G, et al. Hydroxyzine, a first generation H1-receptor antagonist, inhibits human ether-a-go-go-related gene (HERG) current and causes syncope in a patient with the HERG mutation. J Pharmacol Sci 2008; 108(4): 462–71
Reference
Gammon DC, Bhatt MS, Patel B, et al. Managing reduced methotrexate clearance in a patient with a heterozygous methylenetetrahydrofolate reductase gene polymorphism. J Oncol Pharm Pract 2008; 14(3): 153–6
Reference
Boyd EM, Bench AJ, Vaghela KJ, et al. Therapy-related acute myeloid leukaemia with t(8;16)(p1 1;p13);MOZ-CBP and polymorphisms in detoxifying and DNA repair genes. Leukemia 2009; 23(6): 1164–7
Reference
Takane H, Kawamoto K, Sasaki T, et al. Life-threatening toxicities in a patient with UGT1A1*6/*28 and SLCO1B1*15/*15 genotypes after irinotecan-based chemotherapy. Cancer Chemother Pharmacol 2009; 63(6): 1165–9
Reference
Shahrokni A, Rajebi MR, Harold L, et al. Cardiotoxicity of 5-fluorouracil and capecitabine in a pancreatic cancer patient with a novel mutation in the dihydropyrimidine dehydrogenase gene. JOP 2009; 10(2): 215–20
Reference
Sasaki M, Isobe Y, Tsukune Y, et al. Thalidomide may induce interstitial pneumonia preferentially in Japanese patients. Eur J Haematol 2009; 82(1): 73–4
Reference
Martin AF, Figueroa SC, De La Paz Valverde Merino M, et al. Hyperhidrosis in association with efavirenz. AIDS Patient Care STDS 2009; 23(3): 143–5
Reference
Van Luin M, Brouwer A-M, van der Ven A, et al. Efavirenz dose reduction to 200 mg once daily in a patient treated with rifampicin. AIDS 2009; 23(6): 742–4
Reference
Goldstein JA, Blaisdell JA, Limdi NA. A potentially deleterious new CYP2C9 polymorphism identified in an African American patient with major hemorrhage on warfarin therapy. Blood Cells Mol Dis 2009; 42(2): 155–8
Reference
Ayada M, Ishikawa T, Okumura A, et al. A patient with Gilbert’s syndrome complicated with drug-induced liver injury by the over-the-counter drug and fluvastatin sodium: a case report. Acta Hepatologica Japonica 2009; 50(3): 139–44
Reference
Suzuki Y, Niitsu N, Hayama M, et al. Lymphoproliferative disorders after immunosupressive therapy for aplastic anemia: a case report and literature review. Acta Haematol 2009; 121(1): 21–6
Reference
Calligaris L, Stocco G, De Iudicibus S, et al. Carbamazepine hypersensitivity syndrome triggered by a human herpes virus reactivation in a genetically predisposed patient. Int Arch Allergy Immunol 2009; 149(2): 173–7
Reference
Bardini G, Rotella CM, Giannini S, et al. A link between hyperlipidemia and lithium? Confirmation of a recent previous observation. Metabolism 2009; 58(5): 735–7
Reference
Madadi P, Ross CJD, Hayden MR, et al. Pharmacogenetics of neonatal opioid toxicity following maternal use of codeine during breastfeeding: a case-control study. Clin Pharmacol Ther 2009; 85(1): 31–5
Reference
US FDA. FDA and international consortium report new data on drug-induced liver injury [media release]. 2009 May 21 [online]. Available from URL: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm163067.htm [Accessed 2009 Aug 11]
Reference
Cincinnati Children’s Hospital Medical Center. Gene mutation increases drug toxicity, rejection risk in pediatric kidney transplants [media release]. 2009 Feb 18 [online]. Available from: URL: http://www.cincinnatichildrens.org/about/news/release/2009/rejection-risk-kidney-transplants-2-18-09.htm [Accessed 2009 Aug 11]
Rights and permissions
About this article
Cite this article
From the Literature. Mol Diag Ther 13, 269–275 (2009). https://doi.org/10.1007/BF03256332
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03256332